Rachel is interested in the design and application of new chemical tools for target identification and imaging in biological systems to improve clinical diagnosis of cancer and neurodegenerative diseases. She received her MSci in Chemistry with Medicinal Chemistry from Imperial College London and her PhD in Chemical Biology from University of Oxford where she worked on target elucidation of proneurogenic molecules for regenerative therapy.